Plain-English translation of NCT06978894 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are developing a new way to predict when people with early psychosis might relapse (have their symptoms return or worsen). The study analyzes speech patterns—how people talk, the words they use, and how they sound—using artificial intelligence to spot early warning signs. If successful, this could help doctors step in with treatment before a relapse happens.
Right now, doctors don't have a reliable way to predict who will relapse. By catching warning signs early through voice analysis, doctors could help prevent relapses before they happen, keeping people healthier and reducing hospital visits.
You likely qualify if…
You likely don't qualify if…
You would visit one of three Early Psychosis Intervention clinics in Ontario or Quebec for regular appointments. During these visits, researchers will record your voice and speech during conversations, and you'll complete some assessments. The study will track you over time to see if changes in your speech patterns can predict when you might relapse, helping researchers build and test this new early warning system.
AI-generated summary from trial data · Jul 2, 2026 · Not medical advice
Canada
Sponsor
Douglas Mental Health University Institute
Enrollment target
~250 participants
Started
May 2024
Primary completion
July 2028
Age range
16 Years and older
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Lena Palaniyappan, MD, PHD
Douglas Mental Health University Institute
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.